Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $12.5

Twilio (TWLO) Surges 6.9%: Is This an Indication of Further Gains?

Twilio (TWLO) shares surged 6.9% to $284.53 following strong second-quarter results with 22% revenue growth to $1.5 billion and accelerating organic growth of 17%. The company raised its full-year 2026 organic revenue growth outlook to 13%-13.5%, driven by strength in messaging, voice, and software add-ons. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock may struggle to sustain momentum without further positive estimate revisions.

Cellebrite Announces Board Authorized Corporate Reorganization To Redomicile In U.S. With New American Parent Company, Subject To Shareholder And Regulatory Approvals; Expects Completion By H1 2027

Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15

Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $21 to $15.

JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $16

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and lowers the price target from $20 to $16.